title: [Daclatasvir/sofosbuvir is effective also in advanced liver disease].
authors.affiliation: .
authors.forename: Andrea
authors.initials: A
authors.lastname: Warpakowski
mesh_terms: D002219:Carbamates; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000821:virology; D011759:Pyrrolidines; D012254:Ribavirin / Q000008:administration & dosage; D000069474:Sofosbuvir / Q000008:administration & dosage*; D014633:Valine / Q000031:analogs & derivatives
chemical_list: D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D012254:Ribavirin; D014633:Valine; C549273:daclatasvir; D000069474:Sofosbuvir